Ted Okon, Executive Director at Community Oncology Alliance, shared a post on LinkedIn:
“Just Out
Our Perspective in JCO Oncology Practice on the new ASCO policy position on 340B.
340B discounts should go to patients in need, not wealthy hospital systems. Congress never intended hospitals, and now corporate PBMs, from profiting off of 340B.”
Title: Participation Is Not Reform: Why 340B Discounts Should Follow the Patient
Authors: Ted Okon, Nicolas Ferreyros
Read the Full Article.
Other articles from JCO Oncology Practice on OncoDaily.